FN3K and hepatocellular carcinoma: FN3K is reported to be involved in deglycating the Nrf2 through phosphorylation of lysine, and arginine and enhancing Nrf2 activity in hepatocellular carcinoma, consequently protecting the cancer cells through antioxidant mechanisms [4].